Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Since the first description of the association between chronic kidney disease and heart
disease, many epidemiological studies have confirmed and extended this finding. As …
disease, many epidemiological studies have confirmed and extended this finding. As …
[HTML][HTML] Lipotoxicity in kidney, heart, and skeletal muscle dysfunction
H Nishi, T Higashihara, R Inagi - Nutrients, 2019 - mdpi.com
Dyslipidemia is a common nutritional and metabolic disorder in patients with chronic kidney
disease. Accumulating evidence supports the hypothesis that prolonged metabolic …
disease. Accumulating evidence supports the hypothesis that prolonged metabolic …
Chronic kidney disease as a coronary artery disease risk equivalent
A Briasoulis, GL Bakris - Current cardiology reports, 2013 - Springer
Chronic kidney disease (CKD) is associated with accelerated cardiovascular disease (CVD)
risk and a higher CVD event rate. Substantial data from prospective cohort studies support …
risk and a higher CVD event rate. Substantial data from prospective cohort studies support …
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from …
Aims Statins reduce cardiovascular risk in patients with acute coronary syndrome (ACS) and
normal-to-moderately impaired renal function. It is not known whether proprotein convertase …
normal-to-moderately impaired renal function. It is not known whether proprotein convertase …
Intersection between chronic kidney disease and cardiovascular disease
Abstract Purpose of Review The incidence of chronic kidney disease is increasing
worldwide, and the previously decreasing incidence of cardiovascular disease has now …
worldwide, and the previously decreasing incidence of cardiovascular disease has now …
The role of prognostic and predictive biomarkers for assessing cardiovascular risk in chronic kidney disease patients
M Provenzano, M Andreucci… - BioMed research …, 2020 - Wiley Online Library
Chronic kidney disease (CKD) is currently defined as the presence of proteinuria and/or an
eGFR< 60 mL/min/1.73 m2 on the basis of the renal diagnosis. The global dimension of …
eGFR< 60 mL/min/1.73 m2 on the basis of the renal diagnosis. The global dimension of …
Chronic kidney disease measures for cardiovascular risk prediction
Chronic kidney disease (CKD) affects 15–20% of adults globally and causes various
complications, one of the most important being cardiovascular disease (CVD). CKD has …
complications, one of the most important being cardiovascular disease (CVD). CKD has …
[PDF][PDF] Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions.
S Sudhakaran, T Bottiglieri… - Reviews in …, 2018 - pdfs.semanticscholar.org
The incidence of chronic kidney disease (CKD) is growing rapidly and remains a major
cause of morbidity and mortality in the United States. The Kidney Disease Improving Global …
cause of morbidity and mortality in the United States. The Kidney Disease Improving Global …
[HTML][HTML] The Clinical Significance of LDL-Cholesterol on the Outcomes of Hemodialysis Patients with Acute Coronary Syndrome
K Cohen-Hagai, S Benchetrit, O Wand, A Grupper… - Medicina, 2023 - mdpi.com
Background and objectives: Dyslipidemia is one of the most important modifiable risk factors
in the pathogenesis of cardiovascular disease in the general population, but its importance …
in the pathogenesis of cardiovascular disease in the general population, but its importance …
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials
Objective: The available data on statin effects in chronic kidney disease (CKD) patients are
still conflicting. We investigated the impact of short-and long-term statin therapy on lipid …
still conflicting. We investigated the impact of short-and long-term statin therapy on lipid …